A detailed history of Abrdn PLC transactions in Biogen Inc. stock. As of the latest transaction made, Abrdn PLC holds 568,510 shares of BIIB stock, worth $89.8 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
568,510
Previous 535,177 6.23%
Holding current value
$89.8 Million
Previous $124 Million 11.18%
% of portfolio
0.21%
Previous 0.24%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$189.07 - $236.8 $6.3 Million - $7.89 Million
33,333 Added 6.23%
568,510 $110 Million
Q2 2024

Aug 09, 2024

BUY
$190.52 - $236.72 $15.1 Million - $18.8 Million
79,313 Added 17.4%
535,177 $124 Million
Q1 2024

May 08, 2024

BUY
$212.02 - $267.71 $3.98 Million - $5.03 Million
18,789 Added 4.3%
455,864 $98.3 Million
Q4 2023

Jan 31, 2024

BUY
$222.59 - $267.94 $68.5 Million - $82.4 Million
307,532 Added 237.4%
437,075 $113 Million
Q3 2023

Nov 06, 2023

BUY
$253.3 - $285.89 $1.69 Million - $1.91 Million
6,664 Added 5.42%
129,543 $33.3 Million
Q2 2023

Jun 20, 2024

BUY
$275.25 - $318.06 $2.3 Million - $2.66 Million
8,372 Added 7.31%
122,879 $35 Million
Q2 2023

Aug 04, 2023

BUY
$275.25 - $318.06 $2.3 Million - $2.66 Million
8,372 Added 7.31%
122,879 $35 Million
Q1 2023

Jun 20, 2024

BUY
$256.56 - $292.34 $2.61 Million - $2.97 Million
10,174 Added 9.75%
114,507 $31.8 Million
Q1 2023

Apr 28, 2023

BUY
$256.56 - $292.34 $2.61 Million - $2.97 Million
10,174 Added 9.75%
114,507 $31.8 Million
Q4 2022

Jun 20, 2024

SELL
$252.44 - $306.72 $88.7 Million - $108 Million
-351,531 Reduced 77.11%
104,333 $28.9 Million
Q4 2022

Feb 09, 2023

BUY
$252.44 - $306.72 $1.67 Million - $2.02 Million
6,597 Added 6.75%
104,333 $28.9 Million
Q3 2022

Nov 10, 2022

BUY
$194.69 - $268.46 $7.51 Million - $10.4 Million
38,598 Added 65.27%
97,736 $26.1 Million
Q2 2022

Aug 05, 2022

BUY
$187.54 - $223.02 $999,775 - $1.19 Million
5,331 Added 9.91%
59,138 $12.1 Million
Q1 2022

May 04, 2022

SELL
$193.77 - $244.14 $2.18 Million - $2.74 Million
-11,238 Reduced 17.28%
53,807 $11.4 Million
Q4 2021

Feb 08, 2022

SELL
$223.92 - $287.77 $433,509 - $557,122
-1,936 Reduced 2.89%
65,045 $15.6 Million
Q3 2021

Nov 15, 2021

BUY
$282.99 - $369.05 $655,687 - $855,088
2,317 Added 3.58%
66,981 $19.1 Million
Q2 2021

Aug 10, 2021

SELL
$259.0 - $414.71 $893,809 - $1.43 Million
-3,451 Reduced 5.07%
64,664 $22.4 Million
Q1 2021

May 06, 2021

BUY
$242.95 - $284.63 $1.82 Million - $2.14 Million
7,506 Added 12.38%
68,115 $19.1 Million
Q4 2020

Feb 10, 2021

SELL
$236.26 - $355.63 $3.44 Million - $5.18 Million
-14,557 Reduced 19.37%
60,609 $14.8 Million
Q3 2020

Oct 21, 2020

SELL
$264.77 - $305.71 $3.16 Million - $3.65 Million
-11,940 Reduced 13.71%
75,166 $21.3 Million
Q2 2020

Aug 10, 2020

SELL
$258.66 - $342.55 $6.12 Million - $8.1 Million
-23,656 Reduced 21.36%
87,106 $23.3 Million
Q1 2020

May 13, 2020

SELL
$268.85 - $341.04 $3.08 Million - $3.91 Million
-11,458 Reduced 9.37%
110,762 $35 Million
Q4 2019

Feb 18, 2020

SELL
$220.06 - $304.07 $1.45 Million - $2 Million
-6,567 Reduced 5.1%
122,220 $36.3 Million
Q3 2019

Nov 13, 2019

SELL
$217.44 - $243.88 $19.5 Million - $21.9 Million
-89,720 Reduced 41.06%
128,787 $30 Million
Q2 2019

Aug 13, 2019

BUY
$219.29 - $241.72 $1.4 Million - $1.54 Million
6,390 Added 3.01%
218,507 $51.1 Million
Q1 2019

May 14, 2019

BUY
$216.71 - $338.96 $16 Million - $25.1 Million
73,982 Added 53.56%
212,117 $50.1 Million
Q4 2018

Feb 12, 2019

BUY
$278.5 - $352.75 $3.67 Million - $4.65 Million
13,168 Added 10.54%
138,135 $40.7 Million
Q3 2018

Nov 13, 2018

BUY
$293.51 - $383.83 $2.38 Million - $3.11 Million
8,097 Added 6.93%
124,967 $44.2 Million
Q2 2018

Aug 09, 2018

BUY
$257.52 - $306.91 $2.71 Million - $3.23 Million
10,512 Added 9.88%
116,870 $33.9 Million
Q1 2018

May 15, 2018

SELL
$260.13 - $367.91 $538,729 - $761,941
-2,071 Reduced 1.91%
106,358 $29.1 Million
Q4 2017

Feb 12, 2018

SELL
$307.64 - $344.58 $1.6 Million - $1.79 Million
-5,191 Reduced 4.57%
108,429 $34.5 Million
Q3 2017

Nov 14, 2017

BUY
$281.15 - $329.69 $31.9 Million - $37.5 Million
113,620
113,620 $35.6 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.8B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.